Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Associations of plasma phospholipid cis-vaccenic acid with insulin resistance markers in non-diabetic men with hyperlipidemia

J. Macášek, B. Staňková, A. Žák, M. Růžičková, R. Brůha, S. Kutová, M. Vecka, M. Zeman

. 2024 ; 14 (1) : 73. [pub] 20240911

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc24018934

Grantová podpora
Charles University Research Program, Cooperatio-Gastroenterology Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
Charles University Research Program, Cooperatio-Gastroenterology Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
Charles University Research Program, Cooperatio-Gastroenterology Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
Charles University Research Program, Cooperatio-Gastroenterology Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
MH CZ DRO-VFN64165 Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
MH CZ DRO-VFN64165 Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
MH CZ DRO-VFN64165 Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
NU23-01-00288 Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
MH CZ DRO-VFN64165 Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)

BACKGROUND: The role of fatty acids (FA) in the pathogenesis of insulin resistance and hyperlipidemia is a subject of intensive research. Several recent works have suggested cis-vaccenic acid (cVA) in plasma lipid compartments, especially in plasma phospholipids (PL) or erythrocyte membranes, could be associated with markers of insulin sensitivity and cardiovascular health. Nevertheless, not all the results of research work testify to these beneficial effects of cVA. Therefore, we decided to investigate the relations of proportion of cVA in plasma PL to markers of insulin resistance in hyperlipidemic men. SUBJECTS: In 231 men (median age 50) with newly diagnosed hyperlipidemia, we analyzed basic clinical parameters together with FA composition of plasma PL and stratified them according to the content of cVA into upper quartile (Q4) and lower quartile (Q1) groups. We examined also small control group of 50 healthy men. RESULTS: The individuals in Q4 differed from Q1 by lower plasma insulin (p < 0.05), HOMA-IR values (p < 0.01), and apolipoprotein B concentrations (p < 0.001), but by the higher total level of nonesterified FA (p < 0.01). Both groups had similar age, anthropometrical, and other lipid parameters. In plasma PL, the Q4 group had lower content of the sum of n-6 polyunsaturated FA, due to decrease of γ-linolenic and dihomo-γ-linolenic acids, whereas the content of monounsaturated FA (mainly oleic and palmitoleic) was in Q4 higher. CONCLUSIONS: Our results support hypothesis that plasma PL cVA could be associated with insulin sensitivity in men with hyperlipidemia.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24018934
003      
CZ-PrNML
005      
20241024111201.0
007      
ta
008      
241015s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41387-024-00332-z $2 doi
035    __
$a (PubMed)39261487
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Macášek, Jaroslav $u Fourth Department of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague, Czech Republic
245    10
$a Associations of plasma phospholipid cis-vaccenic acid with insulin resistance markers in non-diabetic men with hyperlipidemia / $c J. Macášek, B. Staňková, A. Žák, M. Růžičková, R. Brůha, S. Kutová, M. Vecka, M. Zeman
520    9_
$a BACKGROUND: The role of fatty acids (FA) in the pathogenesis of insulin resistance and hyperlipidemia is a subject of intensive research. Several recent works have suggested cis-vaccenic acid (cVA) in plasma lipid compartments, especially in plasma phospholipids (PL) or erythrocyte membranes, could be associated with markers of insulin sensitivity and cardiovascular health. Nevertheless, not all the results of research work testify to these beneficial effects of cVA. Therefore, we decided to investigate the relations of proportion of cVA in plasma PL to markers of insulin resistance in hyperlipidemic men. SUBJECTS: In 231 men (median age 50) with newly diagnosed hyperlipidemia, we analyzed basic clinical parameters together with FA composition of plasma PL and stratified them according to the content of cVA into upper quartile (Q4) and lower quartile (Q1) groups. We examined also small control group of 50 healthy men. RESULTS: The individuals in Q4 differed from Q1 by lower plasma insulin (p < 0.05), HOMA-IR values (p < 0.01), and apolipoprotein B concentrations (p < 0.001), but by the higher total level of nonesterified FA (p < 0.01). Both groups had similar age, anthropometrical, and other lipid parameters. In plasma PL, the Q4 group had lower content of the sum of n-6 polyunsaturated FA, due to decrease of γ-linolenic and dihomo-γ-linolenic acids, whereas the content of monounsaturated FA (mainly oleic and palmitoleic) was in Q4 higher. CONCLUSIONS: Our results support hypothesis that plasma PL cVA could be associated with insulin sensitivity in men with hyperlipidemia.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a inzulinová rezistence $7 D007333
650    _2
$a lidé středního věku $7 D008875
650    12
$a biologické markery $x krev $7 D015415
650    12
$a fosfolipidy $x krev $7 D010743
650    12
$a hyperlipidemie $x krev $7 D006949
650    _2
$a dospělí $7 D000328
650    12
$a kyseliny olejové $x krev $7 D009829
650    _2
$a inzulin $x krev $7 D007328
650    _2
$a apolipoproteiny B $x krev $7 D001055
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Staňková, Barbora $u Fourth Department of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague, Czech Republic $u Institute of Clinical Chemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Na Bojišti 3, 121 08, Prague, Czech Republic
700    1_
$a Žák, Aleš $u Fourth Department of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague, Czech Republic
700    1_
$a Růžičková, Markéta $u Fourth Department of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague, Czech Republic
700    1_
$a Brůha, Radan $u Fourth Department of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague, Czech Republic
700    1_
$a Kutová, Simona $u Fourth Department of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague, Czech Republic
700    1_
$a Vecka, Marek $u Fourth Department of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague, Czech Republic. marek.vecka@lf1.cuni.cz $u Institute of Clinical Chemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Na Bojišti 3, 121 08, Prague, Czech Republic. marek.vecka@lf1.cuni.cz $1 https://orcid.org/0000000232691817 $7 xx0076497
700    1_
$a Zeman, Miroslav $u Fourth Department of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague, Czech Republic
773    0_
$w MED00181736 $t Nutrition & diabetes $x 2044-4052 $g Roč. 14, č. 1 (2024), s. 73
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39261487 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024111155 $b ABA008
999    __
$a ok $b bmc $g 2201659 $s 1230907
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 14 $c 1 $d 73 $e 20240911 $i 2044-4052 $m Nutrition & diabetes $n Nutr Diabetes $x MED00181736
GRA    __
$a Charles University Research Program, Cooperatio-Gastroenterology $p Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
GRA    __
$a Charles University Research Program, Cooperatio-Gastroenterology $p Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
GRA    __
$a Charles University Research Program, Cooperatio-Gastroenterology $p Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
GRA    __
$a Charles University Research Program, Cooperatio-Gastroenterology $p Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
GRA    __
$a MH CZ DRO-VFN64165 $p Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
GRA    __
$a MH CZ DRO-VFN64165 $p Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
GRA    __
$a MH CZ DRO-VFN64165 $p Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
GRA    __
$a NU23-01-00288 $p Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
GRA    __
$a MH CZ DRO-VFN64165 $p Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...